Global Carrier Screening Market was valued at USD 1,245.4 Million in 2023 and
is expected to reach USD 3260 Million by 2030, Growing at a CAGR of 12.6% from
2023 to 2030.
Global Carrier Screening Market is expected to experience significant growth in
the coming years due to increasing awareness about genetic disorders, advances
in genetic testing technologies, and increasing government initiatives to
promote carrier screening. Carrier screening is a type of genetic testing that
helps identify individuals who are carriers of certain genetic conditions or
diseases, even if they do not have symptoms themselves. Carrier screening is
typically offered to individuals who have a family history of a genetic
condition or are planning to have children.
Impact of Covid-19 Pandemic on Carrier
COVID-19 pandemic has had a significant impact on the carrier screening market.
The demand for carrier screening has increased as individuals have become more
concerned about the potential for genetic conditions being passed on to their
children. Additionally, the pandemic has disrupted supply chains and disrupted
the availability of carrier screening tests, leading to delays in testing and
reduced capacity for testing.
Carrier Screening Market Segmentation
- Targeted Carrier Screening
- Expanded Carrier Screening
- Customized Panel Testing
- Predesigned Panel Testing
- Haematological Conditions
- Pulmonary Conditions
- Neurological Conditions
Services and Products
Players of Global Carrier Screening Market
- Myriad Genetics
- Thermo Fisher Scientific
- F.Hoffmann-La Roche
- Laboratory Corporation of America Holdings
- Centogene N.V.
This type of carrier screening tests for
specific genetic conditions that are known to be prevalent in a particular
population or that are of particular concern to the individual being tested.
This type of carrier screening tests for a
wider range of genetic conditions, including both common and rare conditions.
This type of carrier screening involves
testing for a specific set of genetic conditions that are selected by the
individual being tested or their healthcare provider.
This type of carrier screening involves
testing for a predetermined set of genetic conditions that are commonly
included in carrier screening panels.
different types of carrier screening tests available include targeted carrier
screening, expanded carrier screening, customized panel testing, and
predesigned panel testing. Each of these types of carrier screening tests has
its own advantages and disadvantages, and the appropriate type of testing will
depend on the specific needs and circumstances of the individual being tested.
By Medical Condition
These are conditions that affect the blood
and blood-forming tissues, such as sickle cell anaemia and thalassemia.
These are conditions that affect the
respiratory system, such as cystic fibrosis.
These are conditions that affect the nervous
system, such as spinal muscular atrophy.
screening is a type of genetic testing that is used to determine whether an
individual is a carrier of a genetic condition. Carrier screening is often
offered to people who are planning to have children or who have a family
history of a genetic condition. The carrier screening market is driven by the
increasing prevalence of genetic conditions and the increasing awareness of the
importance of carrier screening.
By Services and Products
These include the various types of carrier screening tests that are available,
such as blood tests, saliva tests, and cheek swab tests.
These include the various services that are provided in conjunction with
carrier screening, such as genetic counselling and interpretation of test
carrier screening market can be segmented by services and products. The
services segment includes pre-conception carrier screening, prenatal carrier
screening, and new born screening. The products segment includes kits and
reagents, software, and services.
Recent Development on Carrier
have been several recent developments in the carrier screening market,
including the introduction of new carrier screening tests, the expansion of
carrier screening into developing countries, and the increasing use of
non-invasive prenatal testing (NIPT) as a form of carrier screening.
Type Insights on Carrier Screening Market
Carrier screening tests use a variety of
technologies, including DNA sequencing, microarray analysis, and PCR
(polymerase chain reaction). Each of these technologies has its own advantages
and disadvantages, and the appropriate technology will depend on the specific
needs and circumstances of the individual being tested.
Carrier Screening Market is highly geographically segmented, with different
regions having different market dynamics. The market in North America is the
largest due to the high adoption of carrier screening in the region. However,
the market in Asia Pacific is expected to grow at the highest CAGR due to the
increasing awareness of carrier screening and the growing healthcare
infrastructure in the region.
- Rest of Europe
- South Korea
- Rest Of APAC
- Rest of South America
Middle East and Africa
- Saudi Arabia
- South Africa
- Rest Of MEA